메뉴 건너뛰기




Volumn 5, Issue 3, 2012, Pages 134-138

Efficacy and safety of acarbose chewable tablet in patients with type 2 diabetes: A multicentre, randomized, double-blinded, double-dummy positive controlled trial

Author keywords

Acarbose; Chewable tablet; Multicentre randomized controlled trial; Positive control; Type 2 diabetes

Indexed keywords

ACARBOSE; HEMOGLOBIN A1C;

EID: 84865644178     PISSN: 17565383     EISSN: 17565391     Source Type: Journal    
DOI: 10.1111/j.1756-5391.2012.01188.x     Document Type: Article
Times cited : (5)

References (11)
  • 1
    • 0005360283 scopus 로고    scopus 로고
    • Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus
    • World Health Organization Consultation. .
    • World Health Organization Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Report of a WHO Consultation Geneva 1999.
    • (1999) Report of a WHO Consultation Geneva
  • 2
  • 3
    • 0031678614 scopus 로고    scopus 로고
    • 1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate
    • 1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate. Diabetes Care 1998; 21: 1612-7
    • (1998) Diabetes Care , vol.21 , pp. 1612-1617
    • Wolever, T.M.S.1    Chiasson, J.L.2    Josse, R.G.3
  • 4
    • 18144415490 scopus 로고    scopus 로고
    • Should minimal blood glucose variability become the gold standard of glycemic control?
    • Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? Diabetes Complications 2005; 19: 178-81.
    • (2005) Diabetes Complications , vol.19 , pp. 178-181
    • Hirsch, I.B.1    Brownlee, M.2
  • 5
    • 73449130201 scopus 로고    scopus 로고
    • Comparison of HbA1c in Chinese patients with type 1 or type 2 diabetes randomized to twice daily insulin lispro low mix 25or twice daily human insulin mix 30/70
    • Li Y, Li Q, Li CJ, Wang CJ, Zheng YM, Issa M, et al. Comparison of HbA1c in Chinese patients with type 1 or type 2 diabetes randomized to twice daily insulin lispro low mix 25or twice daily human insulin mix 30/70. Chin Med J 2009; 122: 2540-6.
    • (2009) Chin Med J , vol.122 , pp. 2540-2546
    • Li, Y.1    Li, Q.2    Li, C.J.3    Wang, C.J.4    Zheng, Y.M.5    Issa, M.6
  • 6
    • 33144478510 scopus 로고    scopus 로고
    • The inhibitory effects of berry polyphenols on digestive enzymes
    • McDougall GJ, Stewart D. The inhibitory effects of berry polyphenols on digestive enzymes. Biofactors 2005; 23: 189-95.
    • (2005) Biofactors , vol.23 , pp. 189-195
    • McDougall, G.J.1    Stewart, D.2
  • 7
    • 0037097039 scopus 로고    scopus 로고
    • STOP-NIDDM trial research group. Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: Facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data
    • Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. STOP-NIDDM trial research group. Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: Facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data. Lancet 2002; 359: 2072-7.
    • (2002) Lancet , vol.359 , pp. 2072-2077
    • Chiasson, J.L.1    Josse, R.G.2    Gomis, R.3    Hanefeld, M.4    Karasik, A.5    Laakso, M.6
  • 8
    • 59249088492 scopus 로고    scopus 로고
    • Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes
    • Tibaldi J. Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes. South Med J 2009; 102: 60-6.
    • (2009) South Med J , vol.102 , pp. 60-66
    • Tibaldi, J.1
  • 9
    • 0025823825 scopus 로고
    • Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with dine
    • Hanefeld M, Fischer S, Schulze J, Spengler M, Wargenau M, Schollberg K, et al. Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone. Diabetes Care 1991; 14: 732-7.
    • (1991) Diabetes Care , vol.14 , pp. 732-737
    • Hanefeld, M.1    Fischer, S.2    Schulze, J.3    Spengler, M.4    Wargenau, M.5    Schollberg, K.6
  • 11
    • 33845996154 scopus 로고    scopus 로고
    • Standards of medical care in diabetes-2007
    • American Diabetes Association.
    • American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 2007; 30(Suppl 1): S4-S41.
    • (2007) Diabetes Care , vol.30 , Issue.SUPPL. 1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.